Clinical Study on Hematopoietic Reconstitution in Allo-Hematopoietic Stem Cell Transplant Patients with Leukemia Accelerate by Rhg-Csf and Rhtpo

高蕾,陈幸华,张曦,王庆余,彭贤贵,孔佩艳,刘红,高力,孙爱华

DOI: https://doi.org/10.3969/j.issn.1671-8348.2007.17.003

2007-01-01

Abstract:Objective To explore the clinical effect of hematopoietic reconstitution in allo-hematopoietic stem cell transplant patients with leukemia accelerated by recombinant human-granulocyte colony stimulating factor(rhG-CSF) and recombinant human-thrombopoietin(rhTPO).Methods Fifteen leukemia patients received rhG-CSF(300μg/d) and rhTPO(15 000u/d) from 1d until WBC recovering to 4.0×109/L and platelet recovering to 75×109/L.Results The median days of neutrophile granulocyte up to 0.5×109/L were 15d and the median days of PLT up to 30×109/L were 19d.STR method display donor haemopoiesis on 30d.Some patients had fever,subcutaneous hemorrhage and nasal bleeding.Three patiens had ostalgia before hematopoietic reconstitution.Three patiens had Ⅰ/Ⅱ aGVHD and two patiens had slight cGVHD.Conclusion RhG-CSF and rhTPO administrtion after allo-HSCT can obviously accelerate the recovery of WBC and PLT,reduce the risk of infection and haemorrhage,and shorten the time of hospitalization.